BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Renzulli M, Clemente A, Ierardi AM, Pettinari I, Tovoli F, Brocchi S, Peta G, Cappabianca S, Carrafiello G, Golfieri R. Imaging of Colorectal Liver Metastases: New Developments and Pending Issues. Cancers (Basel) 2020;12:E151. [PMID: 31936319 DOI: 10.3390/cancers12010151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Renzulli M, Clemente A, Spinelli D, Ierardi AM, Marasco G, Farina D, Brocchi S, Ravaioli M, Pettinari I, Cescon M, Reginelli A, Cappabianca S, Carrafiello G, Golfieri R. Gastric Cancer Staging: Is It Time for Magnetic Resonance Imaging? Cancers (Basel) 2020;12:E1402. [PMID: 32485933 DOI: 10.3390/cancers12061402] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Sawatzki M, Güller U, Güsewell S, Husarik DB, Semela D, Brand S. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases. J Hepatol 2021;74:419-27. [PMID: 33065168 DOI: 10.1016/j.jhep.2020.09.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Reginelli A, Clemente A, Sangiovanni A, Nardone V, Selvaggi F, Sciaudone G, Ciardiello F, Martinelli E, Grassi R, Cappabianca S. Endorectal Ultrasound and Magnetic Resonance Imaging for Rectal Cancer Staging: A Modern Multimodality Approach. J Clin Med 2021;10:641. [PMID: 33567516 DOI: 10.3390/jcm10040641] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Freitas PS, Janicas C, Veiga J, Matos AP, Herédia V, Ramalho M. Imaging evaluation of the liver in oncology patients: A comparison of techniques. World J Hepatol 2021; 13(12): 1936-1955 [DOI: 10.4254/wjh.v13.i12.1936] [Reference Citation Analysis]
5 Xu X, Zhou X, Xiao B, Xu H, Hu D, Qian Y, Hu H, Zhou Z, Liu X, Gao J, Slater NKH, Shen Y, Tang J. Glutathione-Responsive Magnetic Nanoparticles for Highly Sensitive Diagnosis of Liver Metastases. Nano Lett 2021;21:2199-206. [PMID: 33600181 DOI: 10.1021/acs.nanolett.0c04967] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
6 Jacobson RA, Bhama AR. Evaluation and Management of Colorectal Cancer Hepatic Metastases. Dis Colon Rectum 2021;64:777-80. [PMID: 33872286 DOI: 10.1097/DCR.0000000000002103] [Reference Citation Analysis]
7 Shi GZ, Chen H, Zeng WK, Gao M, Wang MZ, Zhang HT, Shen J. R2* value derived from multi-echo Dixon technique can aid discrimination between benign and malignant focal liver lesions. World J Gastroenterol 2021; 27(12): 1182-1193 [PMID: 33828393 DOI: 10.3748/wjg.v27.i12.1182] [Reference Citation Analysis]
8 Neuberger J, Cain O. The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics. Hepat Med 2021;13:59-69. [PMID: 34163263 DOI: 10.2147/HMER.S278076] [Reference Citation Analysis]
9 Stollmayer R, Budai BK, Rónaszéki A, Zsombor Z, Kalina I, Hartmann E, Tóth G, Szoldán P, Bérczi V, Maurovich-horvat P, Kaposi PN. Focal Liver Lesion MRI Feature Identification Using Efficientnet and MONAI: A Feasibility Study. Cells 2022;11:1558. [DOI: 10.3390/cells11091558] [Reference Citation Analysis]
10 Pecorelli A, Franceschi P, Braccischi L, Izzo F, Renzulli M, Golfieri R. MRI Appearance of Focal Lesions in Liver Iron Overload. Diagnostics 2022;12:891. [DOI: 10.3390/diagnostics12040891] [Reference Citation Analysis]
11 Wang X, Wang Y, Zhang Z, Zhou M, Zhou X, Zhao H, Xing J, Zhou Y. Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX. Eur J Radiol 2021;143:109887. [PMID: 34454297 DOI: 10.1016/j.ejrad.2021.109887] [Reference Citation Analysis]
12 Kovács A, Bischoff P, Haddad H, Zhou W, Temming S, Schäfer A, Spallek H, Kaupe L, Kovács G, Pinkawa M. Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies. JPM 2022;12:430. [DOI: 10.3390/jpm12030430] [Reference Citation Analysis]